Janux Therapeutics, Inc. (JANX)
NASDAQ: JANX · Real-Time Price · USD
13.31
+0.24 (1.84%)
Feb 9, 2026, 4:00 PM EST - Market closed
Janux Therapeutics Market Cap
Janux Therapeutics has a market cap or net worth of $800.57 million as of February 9, 2026. Its market cap has decreased by -68.86% in one year.
Market Cap
800.57M
Enterprise Value
-192.23M
1-Year Change
-68.86%
Ranking
Category
Stock Price
$13.31
Market Cap Chart
Since the IPO on June 11, 2021, Janux Therapeutics's market cap has increased from $613.73M to $800.57M, an increase of 30.44%. That is a compound annual growth rate of 5.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 786.13M | -5.29% |
| Dec 31, 2025 | 830.04M | -73.11% |
| Dec 31, 2024 | 3.09B | 523.34% |
| Dec 29, 2023 | 495.20M | -9.51% |
| Dec 30, 2022 | 547.22M | -33.35% |
| Dec 31, 2021 | 821.00M | 33.77% |
| Jun 11, 2021 | 613.73M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Xencor | 829.08M |
| Valneva SE | 826.79M |
| Maravai LifeSciences Holdings | 802.92M |
| Omeros | 796.21M |
| YD Bio | 793.21M |
| MiMedx Group | 762.73M |
| KalVista Pharmaceuticals | 753.14M |
| Nektar Therapeutics | 748.77M |